Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Preoperative thrombelastography maximum amplitude predicts massive transfusion in liver transplantation.

Lawson PJ, Moore HB, Moore EE, Stettler GR, Pshak TJ, Kam I, Silliman CC, Nydam TL.

J Surg Res. 2017 Dec;220:171-175. doi: 10.1016/j.jss.2017.05.115. Epub 2017 Jul 27.

PMID:
29180179
2.

Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.

Emond JC, Goodrich NP, Pomposelli JJ, Baker TB, Humar A, Grant DR, Abt P, Friese CE, Fisher RA, Kam I, Sherker AH, Gillespie BW, Merion RM.

Transplantation. 2017 Oct;101(10):2375-2384. doi: 10.1097/TP.0000000000001823.

PMID:
28514251
3.

Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy.

Chirichella TJ, Dunham CM, Zimmerman MA, Phelan EM, Mandell MS, Conzen KD, Kelley SE, Nydam TL, Bak TE, Kam I, Wachs ME.

World J Gastroenterol. 2016 Mar 28;22(12):3392-403. doi: 10.3748/wjg.v22.i12.3392.

4.

Defining long-term outcomes with living donor liver transplantation in North America.

Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.

Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.

5.

Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation for hepatitis C virus: a single-center experience.

Kelly MA, Kaplan M, Nydam T, Wachs M, Bak T, Kam I, Zimmerman MA.

Transplant Proc. 2013 Nov;45(9):3325-8. doi: 10.1016/j.transproceed.2013.04.011.

PMID:
24182811
6.

Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.

Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown RS Jr, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond JC, Stiles JB, Lukose T, Chang MS, Klintmalm G.

Clin Transplant. 2013 Nov-Dec;27(6):829-37. doi: 10.1111/ctr.12224. Epub 2013 Sep 3.

PMID:
24033475
7.

Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury.

Zimmerman MA, Kam I, Eltzschig H, Grenz A.

Am J Transplant. 2013 Oct;13(10):2524-9. doi: 10.1111/ajt.12398. Epub 2013 Aug 7. Review.

8.

Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.

Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G.

Liver Transpl. 2013 Sep;19(9):1020-9. doi: 10.1002/lt.23703.

9.

Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.

Zimmerman MA, Grenz A, Tak E, Kaplan M, Ridyard D, Brodsky KS, Mandell MS, Kam I, Eltzschig HK.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12012-7. doi: 10.1073/pnas.1221733110. Epub 2013 Jun 28. Retraction in: Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5279.

10.

Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.

Zimmerman MA, Tak E, Ehrentraut SF, Kaplan M, Giebler A, Weng T, Choi DS, Blackburn MR, Kam I, Eltzschig HK, Grenz A.

Hepatology. 2013 Nov;58(5):1766-78. doi: 10.1002/hep.26505. Epub 2013 Sep 24.

11.

Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.

Biggins SW, Trotter J, Gralla J, Burton JR Jr, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR.

J Hepatol. 2013 May;58(5):969-76. doi: 10.1016/j.jhep.2012.12.027. Epub 2013 Jan 15.

12.

Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.

Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B.

J Clin Endocrinol Metab. 2012 Sep;97(9):3132-7. doi: 10.1210/jc.2012-1244. Epub 2012 Jun 8.

PMID:
22685233
13.

Complications of living donor hepatic lobectomy--a comprehensive report.

Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM; A2ALL Study Group.

Am J Transplant. 2012 May;12(5):1208-17. doi: 10.1111/j.1600-6143.2011.03972.x. Epub 2012 Feb 15.

14.

Incentives for organ donation: proposed standards for an internationally acceptable system.

Working Group on Incentives for Living Donation, Matas AJ, Satel S, Munn S, Richards JR, Tan-Alora A, Ambagtsheer FJ, Asis MD, Baloloy L, Cole E, Crippin J, Cronin D, Daar AS, Eason J, Fine R, Florman S, Freeman R, Fung J, Gaertner W, Gaston R, Ghahramani N, Ghods A, Goodwin M, Gutmann T, Hakim N, Hippen B, Huilgol A, Kam I, Lamban A, Land W, Langnas A, Lesaca R, Levy G, Liquette R, Marks WH, Miller C, Ona E, Pamugas G, Paraiso A, Peters TG, Price D, Randhawa G, Reed A, Rigg K, Serrano D, Sollinger H, Sundar S, Teperman L, van Dijk G, Weimar W, Danguilan R.

Am J Transplant. 2012 Feb;12(2):306-12. doi: 10.1111/j.1600-6143.2011.03881.x. Epub 2011 Dec 17. Review.

15.

A Decade of Experience Using mTor Inhibitors in Liver Transplantation.

Campsen J, Zimmerman MA, Mandell S, Kaplan M, Kam I.

J Transplant. 2011;2011:913094. doi: 10.1155/2011/913094. Epub 2011 Mar 15.

16.

Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience.

Olthoff KM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, Tong L; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group.

Liver Transpl. 2011 Jul;17(7):789-97. doi: 10.1002/lt.22288.

17.

Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.

Benson AB, Burton JR Jr, Austin GL, Biggins SW, Zimmerman MA, Kam I, Mandell S, Silliman CC, Rosen H, Moss M.

Liver Transpl. 2011 Feb;17(2):149-58. doi: 10.1002/lt.22212.

18.

Choledochoduodenostomy in pediatric liver transplantation.

Campsen J, Zimmerman MA, Narkewicz MR, Sokol RJ, Mandell MS, Kam I, Dovel D, Karrer FM.

Pediatr Transplant. 2011 May;15(3):237-9. doi: 10.1111/j.1399-3046.2010.01338.x. Epub 2011 Jan 9.

PMID:
21214697
19.

Combined piggyback technique and cavoportal hemitransposition for liver transplant.

Campsen J, Kam I.

Case Rep Med. 2010;2010:595289. doi: 10.1155/2010/595289. Epub 2010 Jun 30.

Supplemental Content

Support Center